367 related articles for article (PubMed ID: 19147868)
1. Pharmacogenetics and pharmacogenomics of anticancer agents.
Huang RS; Ratain MJ
CA Cancer J Clin; 2009; 59(1):42-55. PubMed ID: 19147868
[TBL] [Abstract][Full Text] [Related]
2. [Clinical application, limits and perspectives of pharmacogenetic and pharmacokinetic analysis of anticancer drugs].
Chantry AS; Quaranta S; Ciccolini J; Lacarelle B
Ann Biol Clin (Paris); 2014; 72(5):527-42. PubMed ID: 25336126
[TBL] [Abstract][Full Text] [Related]
3. [Irinotecan pharmacogenetics in Japanese cancer patients: roles of UGT1A1*6 and *28].
Sai K; Sawada J; Minami H
Yakugaku Zasshi; 2008 Apr; 128(4):575-84. PubMed ID: 18379174
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics in cancer therapy: is host genome variability important?
Petros WP; Evans WE
Trends Pharmacol Sci; 2004 Sep; 25(9):457-64. PubMed ID: 15559247
[TBL] [Abstract][Full Text] [Related]
5. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
Mladosievicova B; Carter A; Kristova V
Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
[TBL] [Abstract][Full Text] [Related]
6. Cancer pharmacogenomics: current and future applications.
Watters JW; McLeod HL
Biochim Biophys Acta; 2003 Mar; 1603(2):99-111. PubMed ID: 12618310
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics: road to anticancer therapeutics nirvana?
Desai AA; Innocenti F; Ratain MJ
Oncogene; 2003 Sep; 22(42):6621-8. PubMed ID: 14528287
[TBL] [Abstract][Full Text] [Related]
8. Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.
Sai K; Saito Y
Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):967-88. PubMed ID: 21585235
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and irinotecan therapy.
Hahn KK; Wolff JJ; Kolesar JM
Am J Health Syst Pharm; 2006 Nov; 63(22):2211-7. PubMed ID: 17090741
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application.
Lee SY; McLeod HL
J Pathol; 2011 Jan; 223(1):15-27. PubMed ID: 20818641
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?
Perera MA; Innocenti F; Ratain MJ
Pharmacotherapy; 2008 Jun; 28(6):755-68. PubMed ID: 18503403
[TBL] [Abstract][Full Text] [Related]
12. Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
Huang RS; Dolan ME
Pharmacogenomics; 2010 Apr; 11(4):471-4. PubMed ID: 20350124
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan.
Nagar S; Blanchard RL
Drug Metab Rev; 2006; 38(3):393-409. PubMed ID: 16877259
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.
Weng L; Zhang L; Peng Y; Huang RS
Pharmacogenomics; 2013 Feb; 14(3):315-24. PubMed ID: 23394393
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenetics of anticancer drugs].
de Chaisemartin L; Loriot MA
Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
[TBL] [Abstract][Full Text] [Related]
16. Germline pharmacogenomics in oncology: decoding the patient for targeting therapy.
O'Donnell PH; Ratain MJ
Mol Oncol; 2012 Apr; 6(2):251-9. PubMed ID: 22321460
[TBL] [Abstract][Full Text] [Related]
17. An overview of the recent progress in irinotecan pharmacogenetics.
Fujiwara Y; Minami H
Pharmacogenomics; 2010 Mar; 11(3):391-406. PubMed ID: 20235794
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics of tamoxifen and irinotecan therapies.
Algeciras-Schimnich A; O'Kane DJ; Snozek CL
Clin Lab Med; 2008 Dec; 28(4):553-67. PubMed ID: 19059062
[TBL] [Abstract][Full Text] [Related]
20. Update on pharmacogenetics in cancer chemotherapy.
Innocenti F; Ratain MJ
Eur J Cancer; 2002 Mar; 38(5):639-44. PubMed ID: 11916544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]